Stayble Therapeutics AB (publ) (STABL.ST)

SEK 0.46

(4.55%)

Long Term Debt Summary of Stayble Therapeutics AB (publ)

  • Stayble Therapeutics AB (publ)'s latest annual long term debt in 2023 was 850 Thousand SEK , down 0.0% from previous year.
  • Stayble Therapeutics AB (publ)'s latest quarterly long term debt in 2024 Q2 was 850 Thousand SEK , down 0.0% from previous quarter.
  • Stayble Therapeutics AB (publ) reported annual long term debt of 850 Thousand SEK in 2022, down 0.0% from previous year.
  • Stayble Therapeutics AB (publ) reported annual long term debt of 850 Thousand SEK in 2021, down 0.0% from previous year.
  • Stayble Therapeutics AB (publ) reported quarterly long term debt of 850 Thousand SEK for 2024 Q1, down 0.0% from previous quarter.
  • Stayble Therapeutics AB (publ) reported quarterly long term debt of 850 Thousand SEK for 2023 FY, down 0.0% from previous quarter.

Annual Long Term Debt Chart of Stayble Therapeutics AB (publ) (2023 - 2016)

Historical Annual Long Term Debt of Stayble Therapeutics AB (publ) (2023 - 2016)

Year Long Term Debt Long Term Debt Growth
2023 850 Thousand SEK 0.0%
2022 850 Thousand SEK 0.0%
2021 850 Thousand SEK 0.0%
2020 850 Thousand SEK -37.04%
2019 1.35 Million SEK 58.82%
2018 850 Thousand SEK 0.0%
2017 850 Thousand SEK 0.0%
2016 850 Thousand SEK 0.0%

Peer Long Term Debt Comparison of Stayble Therapeutics AB (publ)

Name Long Term Debt Long Term Debt Difference
Active Biotech AB (publ) 3 Million SEK 71.667%
Biovica International AB (publ) 4.29 Million SEK 80.214%
Cantargia AB (publ) - SEK -Infinity%
CombiGene AB (publ) - SEK -Infinity%
Cyxone AB (publ) 74 Thousand SEK -1048.649%
Diagonal Bio AB (publ) - SEK -Infinity%
Elicera Therapeutics AB (publ) - SEK -Infinity%
ExpreS2ion Biotech Holding AB (publ) 1.43 Million SEK 40.808%
Fluicell AB (publ) - SEK -Infinity%
Infant Bacterial Therapeutics AB (publ) - SEK -Infinity%
Mendus AB (publ) 850 Thousand SEK 0.0%
Isofol Medical AB (publ) - SEK -Infinity%
I-Tech AB - SEK -Infinity%
Intervacc AB (publ) 142 Thousand SEK -498.592%
Lipigon Pharmaceuticals AB (publ) - SEK -Infinity%
Magle Chemoswed Holding AB (publ) 32.58 Million SEK 97.391%
Modus Therapeutics Holding AB (publ) - SEK -Infinity%
OncoZenge AB (publ) - SEK -Infinity%
Sprint Bioscience AB (publ) - SEK -Infinity%
Xbrane Biopharma AB (publ) 112.89 Million SEK 99.247%
Lipum AB (publ) 1.76 Million SEK 51.732%
Alligator Bioscience AB (publ) 7.51 Million SEK 88.691%
Ziccum AB (publ) 286 Thousand SEK -197.203%
BioArctic AB (publ) 2.15 Million SEK 60.502%
Genovis AB (publ.) 74.8 Million SEK 98.864%
Camurus AB (publ) 13.61 Million SEK 93.756%
IRLAB Therapeutics AB (publ) 24.51 Million SEK 96.532%
Bio-Works Technologies AB (publ) - SEK -Infinity%
Aptahem AB (publ) - SEK -Infinity%
Vicore Pharma Holding AB (publ) - SEK -Infinity%
Xspray Pharma AB (publ) 31.94 Million SEK 97.339%
Kancera AB (publ) - SEK -Infinity%
Saniona AB (publ) 65.23 Million SEK 98.697%
Spago Nanomedical AB (publ) - SEK -Infinity%
AcouSort AB (publ) - SEK -Infinity%
Xintela AB (publ) - SEK -Infinity%
Abliva AB (publ) 424 Thousand SEK -100.472%
Karolinska Development AB (publ) - SEK -Infinity%
Amniotics AB (publ) - SEK -Infinity%
2cureX AB (publ) - SEK -Infinity%
Asarina Pharma AB (publ) 1 Million SEK 15.0%
Calliditas Therapeutics AB (publ) 939.5 Million SEK 99.91%
Hansa Biopharma AB (publ) 844.9 Million SEK 99.899%
Biosergen AB - SEK -Infinity%
QuiaPEG Pharmaceuticals Holding AB (publ) - SEK -Infinity%
Corline Biomedical AB - SEK -Infinity%
NextCell Pharma AB - SEK -Infinity%
Nanologica AB (publ) 136 Thousand SEK -525.0%
LIDDS AB (publ) - SEK -Infinity%
Egetis Therapeutics AB (publ) 103.4 Million SEK 99.178%
BioInvent International AB (publ) 14.53 Million SEK 94.152%
SynAct Pharma AB 58 Thousand SEK -1365.517%
Annexin Pharmaceuticals AB (publ) - SEK -Infinity%
Alzinova AB (publ) 800 Thousand SEK -6.25%
Ascelia Pharma AB (publ) 176 Thousand SEK -382.955%
Oncopeptides AB (publ) 106.48 Million SEK 99.202%
Pila Pharma AB (publ) - SEK -Infinity%
Guard Therapeutics International AB (publ) - SEK -Infinity%
Scandinavian ChemoTech AB (publ) - SEK -Infinity%
Simris Alg AB (publ) 90.74 Million SEK 99.063%
Diamyd Medical AB (publ) 30.67 Million SEK 97.229%